Population cancer screening: are we getting it right?

Chair: Ian Tomlinson, University of Birmingham, UK
Speaker: Linda Sharp, Newcastle University, UK
Speaker: Mette Kalager, University of Oslo, Norway
Speaker: Richard Martin, University of Bristol, UK


Room: Carron

The session is based around the premise that whilst prevention is evidently better than cure (and early detection is better than late detection), population-based cancer prevention is wasteful, has patchy uptake and uses methods with sub-optimal performance. Nevertheless, truly precision screening will always be limited by the stochastic factors inherent in carcinogenesis. Where does the optimal balance lie between population participation, costs, and minimizing both unnecessary screening and the burden on screening services? How do we identify and reach that balance? Where can we substitute early detection for screening without major health impacts?